Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06573983 · ClinicalTrials.gov registry record · NA

Fall Risk Identification and Management for Older Veterans

A NA study of Fall Risk, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT06573983: Recruiting NA study of Fall Risk, sponsored by VA Office of Research and Development.

NCT06573983 is a NA study of Fall Risk that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 108 participants, above the 51-participant average among 3 other Fall Risk trials with a reported enrollment target (112% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06573983, a NA study of Fall Risk, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

Falls are a common occurrence among older adults, and Veterans have an even higher risk of falling compared to non-Veterans. These falls often lead to severe health consequences, including traumatic brain injuries, hip fractures, emergency visits, hospitalizations, and even death. It is crucial to prioritize fall prevention in order to reduce injuries and enable older Veterans to age comfortably at home. Although current fall prevention programs in the Veterans Health Administration primarily focus on inpatient care and nursing homes, there is a pressing need to address falls among older Veterans living independently in the community. The proposed VA-specific Fall Risk Identification and Management (FRIM) model aims to proactively prevent falls in older Veterans who receive primary care, effectively reducing the occurrence of adverse health events associated with falls. By placing emphasis on prevention rather than reacting after falls have already happened, this initiative seeks to significantly enhance the overall well-being of older Veterans.

Primary Outcome

Participant recruitment will be tracked as part of feasibility. It will be determined as the proportion of Veterans screened as eligible that are recruited.

Conditions Studied

Interventions

  • OTHER Strengthening (Physical Therapy, Gerofit)
  • OTHER Cognitive Behavioral Therapy (Clinical Psychology, Occupational Therapy)
  • OTHER Medication Reconciliation (Clinical Pharmacology)
  • OTHER Home Safety Modification (Occupational Therapy)

Study Locations (1)

Colorado

  • Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2025-02-04
Est. Completion 2029-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT06573983 shows while recruiting

NCT06573983 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, above the 51-participant average among 3 other Fall Risk trials with a reported enrollment target (112% higher).

The record links to 1 condition, with Fall Risk appearing as the primary indexed condition, and to 4 interventions - of which Strengthening (Physical Therapy, Gerofit) is the first listed.

NCT06573983 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT06573983 about?

NCT06573983 is a clinical study titled "Fall Risk Identification and Management for Older Veterans". Falls are a common occurrence among older adults, and Veterans have an even higher risk of falling compared to non-Veterans. These falls often lead to severe health consequences, including traumatic brain injuries, hip fractures, emergency visits, hospitalizations, and even death. It is crucial to p...

What is the current status of trial NCT06573983?

This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2025-02-04. Estimated completion is 2029-09-30.

What conditions does trial NCT06573983 study?

This clinical trial studies the following conditions: Fall Risk.

What interventions are being tested in trial NCT06573983?

The interventions under investigation include: Strengthening (Physical Therapy, Gerofit) (OTHER), Cognitive Behavioral Therapy (Clinical Psychology, Occupational Therapy) (OTHER), Medication Reconciliation (Clinical Pharmacology) (OTHER), Home Safety Modification (Occupational Therapy) (OTHER).

Who is sponsoring clinical trial NCT06573983?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06573983 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fall Risk

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06573983, the US trial registry maintained by the National Library of Medicine. NCT06573983 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.